Richards Melanie L, Wormuth Jennifer, Bingener Juliane, Sirinek Kenneth
Department of Surgery, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Surgery. 2006 Feb;139(2):174-80. doi: 10.1016/j.surg.2005.08.036.
Subtotal parathyroidectomy (SPTX) and total PTX with autotransplantation (TPTX + AT) are both accepted operations for secondary hyperparathyroidism (2HPT). Studies have shown the 2 procedures to have similar rates of recurrent or persistent HPT (0% to 10%). The majority of these reports are small case series and despite apparently similar outcomes; the optimal operative management for 2HPT remains controversial. The purpose of this study was to determine whether there were any clinical outcome differences between these apparently comparable operations.
A meta-analysis of 53 publications on reoperative operation for 2HPT from 1983 to 2004 identified 501 patients who had undergone an operation for recurrent or persistent 2HPT. The data evaluated included the type of initial operation, the need for reoperative operation as it related to the type of initial operation, and the intraoperative findings.
The initial operation had been a SPTX in 36% and a TPTX + AT in 64% of patients. Reoperative operation was for persistent 2HPT in 82 of 485 (17%) and for recurrent 2HPT in 403 of 485 (83%) patients. Findings at reoperation included: autograft hyperplasia (49%), supernumerary glands (20%), remnant hyperplasia (17%), a missed in situ gland (7%), and a negative exploration (5%). Supernumerary glands, missed in situ glands, and negative explorations occurred at equal rates for both operations. Reoperation determined that inadequate cervical explorations occurred in 42% of patients who had undergone a SPTX and in 34% of patients who had undergone a TPTX + AT.
Operative failures occur because of the limitations in preoperative localization, inadequate exploration, and the natural history of hyperplastic parathyroid tissue. The initial operation should include an attempt to localize supernumerary glands both pre- and intra-operatively.
甲状旁腺次全切除术(SPTX)和甲状旁腺全切除术加自体移植术(TPTX + AT)都是治疗继发性甲状旁腺功能亢进(2HPT)的公认手术方法。研究表明,这两种手术的甲状旁腺功能亢进复发或持续发生率相似(0%至10%)。这些报告大多是小病例系列,尽管结果明显相似,但2HPT的最佳手术治疗仍存在争议。本研究的目的是确定这些看似可比的手术之间是否存在任何临床结果差异。
对1983年至2004年期间53篇关于2HPT再次手术的出版物进行荟萃分析,确定了501例因复发性或持续性2HPT接受手术的患者。评估的数据包括初次手术的类型、与初次手术类型相关的再次手术需求以及术中发现。
36%的患者初次手术为SPTX,64%的患者为TPTX + AT。485例患者中有82例(17%)因持续性2HPT接受再次手术,485例患者中有403例(83%)因复发性2HPT接受再次手术。再次手术的发现包括:自体移植增生(49%)、异位甲状旁腺(20%)、残留增生(17%)、遗漏原位甲状旁腺(7%)和探查阴性(5%)。两种手术的异位甲状旁腺、遗漏原位甲状旁腺和探查阴性发生率相同。再次手术发现,接受SPTX的患者中有42%和接受TPTX + AT的患者中有34%存在颈部探查不充分的情况。
手术失败是由于术前定位的局限性、探查不充分以及增生性甲状旁腺组织的自然病程所致。初次手术应包括术前和术中尝试定位异位甲状旁腺。